Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)
CUSIP: 74365A309
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 80,361,978
- Total 13F shares
- 4,315,299
- Share change
- -4,512,690
- Total reported value
- $8,240,101
- Put/Call ratio
- 81%
- Price per share
- $1.91
- Number of holders
- 31
- Value change
- -$19,328,651
- Number of buys
- 19
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74365A309:
Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Psagot Value Holdings Ltd. |
13F
|
Company |
3.9%
|
3,095,741
|
$13,807,000 | — | 31 Mar 2021 | |
| Burrage Capital Management LLC |
13F
|
Company |
2.6%
|
2,125,585
|
$9,480,000 | — | 31 Mar 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
1.5%
|
1,204,825
|
$5,374,000 | — | 31 Mar 2021 | |
| Dexcel Pharma Technologies Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,637,314
|
$5,128,613 | — | 02 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.63%
|
507,634
|
$2,264,000 | — | 31 Mar 2021 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.55%
|
445,171
|
$1,985,000 | — | 31 Mar 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
302,591
|
$1,350,000 | — | 31 Mar 2021 | |
| Phoenix Financial Ltd. |
13F
|
Company |
0.3%
|
244,113
|
$1,089,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
203,813
|
$909,000 | — | 31 Mar 2021 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0.16%
|
130,700
|
$583,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.15%
|
122,184
|
$545,000 | — | 31 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.11%
|
89,278
|
$399,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
66,631
|
$297,000 | — | 31 Mar 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
48,328
|
$215,000 | — | 31 Mar 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.06%
|
44,248
|
$197,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.05%
|
42,813
|
$191,000 | — | 31 Mar 2021 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
27,744
|
$124,000 | — | 31 Mar 2021 | |
| CAPSTONE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.03%
|
21,058
|
$94,000 | — | 31 Mar 2021 | |
| WOLVERINE TRADING, LLC |
13F
|
Company |
0.02%
|
18,798
|
$85,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
15,772
|
$70,000 | — | 31 Mar 2021 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.02%
|
14,684
|
$65,000 | — | 31 Mar 2021 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.01%
|
12,000
|
$54,000 | — | 31 Mar 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
10,000
|
$45,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
6,870
|
$31,000 | — | 31 Mar 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
5,761
|
$26,000 | — | 31 Mar 2021 | |
| WealthShield Partners, LLC |
13F
|
Company |
0%
|
3,000
|
$13,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,195
|
$10,000 | — | 31 Mar 2021 | |
| Spire Wealth Management |
13F
|
Company |
0%
|
2,000
|
$9,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
1,371
|
$6,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,293
|
$6,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,088
|
$5,000 | — | 31 Mar 2021 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1,100
|
$4,906 | — | 31 Mar 2021 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1,000
|
$4,460 | — | 31 Mar 2021 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0%
|
800
|
$4,000 | — | 31 Mar 2021 | |
| Gemmer Asset Management LLC |
13F
|
Company |
0%
|
800
|
$4,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
620
|
$3,000 | — | 31 Mar 2021 | |
| Aspire Private Capital, LLC |
13F
|
Company |
0%
|
400
|
$2,000 | — | 31 Mar 2021 |
Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q2 2021
As of 30 Jun 2021,
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,315,299 shares.
The largest 10 holders included
MORGAN STANLEY, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Walleye Capital LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MEITAV DASH INVESTMENTS LTD, Phoenix Holdings Ltd., GROUP ONE TRADING, L.P., Walleye Trading LLC, BlackRock Inc., and CITADEL ADVISORS LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
36
Q2 2021 holders
31
Holder diff
-5
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.